| Financial Year |
March 31 2023 |
| Monetary Funds |
478,081,931.61 |
| Held-for-trading Financial Assets |
85,505,367.22 |
| Notes Receivable |
8,875,566.67 |
| Accounts Receivable |
217,359,878.84 |
| Advances to Suppliers |
4,410,288.00 |
| Other Receivables |
5,183,173.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
192,000.00 |
| Dividend Receivable |
-- |
| Inventories |
55,270,128.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,510,093.24 |
| Total Current Assets |
871,196,428.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
329,033,441.52 |
| Under-construction Projects |
105,097,736.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,409,487.19 |
| R&D expenses |
-- |
| Goodwill |
24,828,446.37 |
| Long-Term Deferred and Prepaid Expenses |
36,633,552.79 |
| Deferred Income Tax Assets |
13,984,029.51 |
| Other Non-Current Assets |
7,923,929.95 |
| Sub-Total of Non-Current Assets |
623,408,219.69 |
| Total Assets |
1,494,604,648.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
57,017,970.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,152,009.67 |
| Taxes Payable |
5,133,718.83 |
| Interest Payable |
-- |
| Dividend Payable |
463,560.00 |
| Other payables |
47,883,862.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,553,562.77 |
| Other Current Liabilities |
6,086,862.04 |
| Sub-Total of Current Liabilities |
176,928,713.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,068,789.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,961,532.55 |
| Total Liabilities |
260,890,246.44 |
| Paid-In Capital(Or Share Stock) |
113,790,200.00 |
| Capital Surplus |
593,634,843.19 |
| Surplus Reserve |
21,079,826.33 |
| LESS:Treasury Stock |
45,207,062.40 |
| Undistributed Profits |
480,577,821.70 |
| Minority Stockholder's Interest |
69,838,772.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,163,875,628.82 |
| Owner's Equity（Stockholder's Equity） |
1,233,714,401.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,494,604,648.12 |
